1. Home
  2. UNTY vs RCKT Comparison

UNTY vs RCKT Comparison

Compare UNTY & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unity Bancorp Inc.

UNTY

Unity Bancorp Inc.

HOLD

Current Price

$49.00

Market Cap

523.6M

Sector

Finance

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$4.44

Market Cap

534.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNTY
RCKT
Founded
1991
1999
Country
United States
United States
Employees
N/A
202
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
523.6M
534.2M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
UNTY
RCKT
Price
$49.00
$4.44
Analyst Decision
Buy
Buy
Analyst Count
2
14
Target Price
$65.00
$29.65
AVG Volume (30 Days)
29.9K
2.7M
Earning Date
04-10-2026
05-07-2026
Dividend Yield
1.22%
N/A
EPS Growth
39.66
N/A
EPS
5.67
N/A
Revenue
N/A
N/A
Revenue This Year
$11.57
N/A
Revenue Next Year
$8.52
$97.68
P/E Ratio
$8.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$36.65
$2.19
52 Week High
$57.30
$8.80

Technical Indicators

Market Signals
Indicator
UNTY
RCKT
Relative Strength Index (RSI) 30.28 50.69
Support Level $46.88 $2.99
Resistance Level $50.16 $5.39
Average True Range (ATR) 1.38 0.38
MACD -0.27 -0.06
Stochastic Oscillator 4.14 22.09

Price Performance

Historical Comparison
UNTY
RCKT

About UNTY Unity Bancorp Inc.

Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. It conducts a traditional and community-oriented commercial banking business and offers services, including personal and business checking accounts, time deposits, money market accounts, regular savings accounts, and others. The company structures its specific services and charges in a manner designed to attract the business of small and medium-sized businesses and professional communities, as well as individuals residing, working, and shopping in its service area. The company engages in a wide range of lending activities and offers commercial, Small Business Administration, consumer, mortgage, home equity, and personal loans.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: